Loading paragraph...
Today's Biggest Stock Losers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| BUR | Burford Capital | $4.07 | -$3.76 | -48.02% | 1.2M | $1.7B | $3.59$15.10 |
| UGRO | Urban-gro | $17.61 | -$10.39 | -37.11% | 3.4M | $21M | $2.02$37.00 |
| DTCX | Datacentrex | $2.11 | -$0.98 | -31.71% | 4M | $100M | $1.51$16.49 |
| RMCO | Royalty Management | $2.31 | -$0.98 | -29.79% | 272.6K | $50M | $0.91$5.00 |
| AIFF | Firefly Neuroscience | $2.18 | -$0.84 | -27.82% | 7.3M | $43M | $0.62$4.51 |
| FGL | Founder Group | $2.46 | -$0.89 | -26.57% | 195.8K | $57M | $2.30$154.00 |
| SUNE | SUNation Energy | $2.37 | -$0.80 | -25.24% | 1.1M | $11M | $0.68$108.60 |
| ZNTL | Zentalis Pharmaceuticals | $2.11 | -$0.56 | -20.97% | 32.3K | $193M | $1.01$3.95 |
| ROMA | Roma Green Finance | $6.27 | -$1.58 | -20.13% | 32.1K | $468M | $0.72$11.77 |
| CDT | Cdt Equity | $7.85 | -$1.97 | -20.06% | 106.8K | $43M | $7.45$4,200.00 |
| RCKT | Rocket Pharmaceuticals | $3.76 | -$0.94 | -19.94% | 755.8K | $509M | $2.19$8.26 |
| RCAX | Tidal Trust II - Defiance Daily Target 2x Long Rcat ETF | $13.26 | -$3.11 | -19.02% | 402.4K | - | $11.66$31.62 |
| BTM | Bitcoin Depot | $2.02 | -$0.45 | -18.22% | 6.2K | $27M | $2.01$48.16 |
| XXII | 22nd Century Group | $2.41 | -$0.53 | -18.03% | 61.9K | $1.5M | $2.41$841.80 |
| ZBIO | Zenas BioPharma | $18.28 | -$3.88 | -17.51% | 144.4K | $1.3B | $6.11$44.60 |
Related Articles
Featured Article
Rocket Pharmaceuticals Stock Is Blasting Off, but Here's Why You Should Tread Carefully
Alex Carchidi|Sep 18, 2023
Its near-term risks are subtle but bigger than their flying stock price might indicate.
3 Best Marijuana Stocks to Buy in December
Alex Carchidi|Dec 1, 2022
All three are pursuing strategies that are working and will work even better in the long term.
22nd Century Group's Road to Cannabis May Have Some Potholes
Lukas Barfield|Jul 26, 2022
The biotechnology company is working hard to get up to speed, but it risks running out of highway.
This Under-the-Radar Stock Just Got a Huge Gift From the Biden Administration
Alex Carchidi|Jul 8, 2022
It'll benefit from proposed rules that may eventually limit nicotine in cigarettes.
This Little-Known Tobacco Stock Is Getting a Huge Boost
Rich Duprey|Jun 26, 2022
The FDA's plan to reduce nicotine in cigarettes to near zero could mean big sales for this stock.
If Biden Nixes Nicotine, 22nd Century Group Stock Could 10X
Alex Carchidi|Jun 25, 2022
Slashing the amount of nicotine allowed in cigarettes will disrupt the entire cigarette industry in its favor.
22nd Century Group (Finally) Unveils Its Third Business
David Jagielski, CPA|Sep 15, 2021
The company says the total addressable market across all its businesses is $1.3 trillion.
Is 22nd Century Group a Buy?
David Jagielski, CPA|Jun 29, 2021
The company gives investors exposure to three different markets.
An Upcoming FDA Decision on Nicotine Could Send This Stock Soaring
Jeffrey Little|Apr 30, 2021
The same old story could have a different ending this time for investors.
Why 22nd Century Group Stock Just Lit Up
Rich Smith|Mar 12, 2021
Tobacco and marijuana bioengineering? Yeah, that's apparently a thing now.
